Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

NCT00545870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Diabetic Macular Edema
Proliferative Diabetic Retinopathy

Interventions

DRUG: bevacizumab
DRUG: Ranibizumab

Sponsor

Ursula Schmidt-Erfurth, M.D.